Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical advisory board to help the company advance its 3D genomics technologies into the clinical oncology and biopharmaceutical markets.

Related Keywords

Anthony Schmitt ,Matija Snuderl ,Ken Young ,Kenh Young ,Darren Sigal ,Arima Genomics Inc ,Langone Health ,Duke University ,Hematopathology Division ,Professor Of Pathology At Duke University ,Duke Blood Cancer Pathology Program ,Arima Genomics ,Arima Genomic ,Senior Vice President ,Protean Biodiagnostics ,Gabrielle Raia ,